Analysts Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 experts just weighed in on Aerie Pharma (NASDAQ: AERI) and Zimmer Biomet Holdings (NYSE: ZBH) with bullish sentiments.

Aerie Pharma (NASDAQ: AERI)

In a report released today, Donald Ellis from JMP Securities reiterated a Buy rating on Aerie Pharma (NASDAQ: AERI). The company’s shares opened today at $21.15.

According to TipRanks.com, Ellis is a 4-star analyst with an average return of 21.0% and a 77.8% success rate. Ellis covers the Healthcare sector, focusing on stocks such as Anacor Pharmaceuticals, Pacira Pharmaceuticals, and Horizon Pharma Inc.

Currently, the analyst consensus on Aerie Pharma is Strong Buy and the average price target is $44, representing a 108.0% upside.

In a report issued on September 7, Brean Capital also reiterated a Buy rating on the stock with a $48 price target.
Zimmer Biomet Holdings (NYSE: ZBH)

RBC Capital analyst Glenn Novarro reiterated a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH) today and set a price target of $143. The company’s shares opened today at $123.45.

According to TipRanks.com, Novarro is a 4-star analyst with an average return of 3.6% and a 64.2% success rate. Novarro covers the Healthcare sector, focusing on stocks such as Integer Holdings Corporation, Boston Scientific Corp., and Baxter International.

Currently, the analyst consensus on Zimmer Biomet Holdings is Strong Buy and the average price target is $145.83, representing a 18.1% upside.

In a report issued on September 6, Merrill Lynch also reiterated a Buy rating on the stock with a $155 price target.